| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of RFC3 mRNA | increases expression | 20713471
|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of RFC3 mRNA | affects expression | 21346803
|
| D001374 |
Azacitidine |
[Azacitidine co-treated with Thalidomide] affects the expression of RFC3 mRNA | affects cotreatment|affects expression | 18720364
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RFC3 mRNA | decreases expression | 19150397 20382639
|
| D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of RFC3 mRNA | decreases expression | 15336504
|
| D003345 |
Corticosterone |
Corticosterone results in decreased expression of RFC3 mRNA | decreases expression | 15755911
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of RFC3 mRNA | decreases expression | 20106945
|
| D004317 |
Doxorubicin |
RFC3 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of RFC3 mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RFC3 mRNA | affects cotreatment|increases expression | 17942748
|
| D005472 |
Fluorouracil |
RFC3 protein affects the susceptibility to Fluorouracil | affects response to substance | 15548681
|
| D019833 |
Genistein |
Genistein results in increased expression of RFC3 mRNA | increases expression | 17341692
|
| C051890 |
irinotecan |
irinotecan metabolite results in decreased expression of RFC3 mRNA | decreases expression | 15956246
|
| C051890 |
irinotecan |
irinotecan results in decreased expression of RFC3 mRNA | decreases expression | 15956246
|
| C051890 |
irinotecan |
RFC3 protein results in increased susceptibility to irinotecan | increases response to substance | 16734730
|
| D008294 |
Malathion |
Malathion results in decreased expression of RFC3 mRNA | decreases expression | 16079077
|
| D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of RFC3 mRNA | increases expression | 20713471
|
| D016685 |
Mitomycin |
RFC3 protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RFC3 mRNA | affects binding|decreases expression|increases activity | 19710929
|
| C006253 |
pirinixic acid |
pirinixic acid results in increased expression of RFC3 mRNA | increases expression | 17950772
|
| C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of RFC3 mRNA] | increases expression|increases reaction | 17950772
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RFC3 mRNA | affects cotreatment|increases expression | 17942748
|
| D013792 |
Thalidomide |
[Azacitidine co-treated with Thalidomide] affects the expression of RFC3 mRNA | affects cotreatment|affects expression | 18720364
|
| C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of RFC3 mRNA | decreases expression | 17951470
|
| D014212 |
Tretinoin |
Tretinoin results in decreased expression of RFC3 mRNA | decreases expression | 16054129
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.42 | 15322242 11752688 14514962 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
8.42 | 8333272 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.86 | 17505938 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.03 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
10.02 | 17418594 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
10.02 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
10.02 | 17638652 |
| MESH:D000230 |
Adenocarcinoma |
|
Genistein |
10.02 | 11473722 |
| MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
3.45 | 6695378 10545420 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.62 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.62 | 16835633 |
| MESH:D000382 |
Agricultural Workers' Diseases |
|
Malathion |
4.89 | 17119214 11874814 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.46 | 21441931 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.54 | 15955085 |
| MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
4.30 | 16510725 |
| MESH:D000740 |
Anemia |
|
Fluorouracil |
8.42 | 17963324 16511603 15504547 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.42 | 11748828 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.38 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
12.06 | 15885639 |
| MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
12.06 | 9598899 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
12.06 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.32 | 16456186 |
| MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.40 | 11922910 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.32 | 16935849 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.79 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.79 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.79 | 16197459 16206674 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.71 | 15746008 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.62 | 14601052 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.73 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
4.67 | 11921183 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.67 | 11325840 16322301 16115903 16935488 17983394 15668708 15136595 15993339 16096432 15692762 17369602 16595493 19526202 17426702 18628466 18234424 16264153 16826403 15939500 18695136 15567936 15634643 18382427 15994142 |
| MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
4.67 | 16110121 16595493 19217205 18357371 18608205 15136595 16557594 |
| MESH:D001943 |
Breast Neoplasms |
|
Genistein |
4.67 | 16873071 17200150 16541309 |
| MESH:D001943 |
Breast Neoplasms |
|
Malathion |
4.67 | 12762645 |
| MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
4.67 | 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.67 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.67 | 16166294 16443354 16873071 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.50 | 16813970 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.08 | 16051944 |
| MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
12.08 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Fluorouracil |
13.57 | 17121937 |
| MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
13.57 | 10545420 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
13.57 | 16835633 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.08 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
11.22 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
11.22 | 18059187 16234567 17876044 16023760 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
11.22 | 18930000 16332177 16799960 17088986 17971768 17045692 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
11.22 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
11.22 | 16313753 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
11.22 | 1917145 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.54 | 16201981 1485588 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.54 | 18695887 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.46 | 6189445 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.46 | 16757204 18986760 16280240 17066447 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.46 | 16051514 16096774 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.32 | 16120746 18850075 18670907 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.47 | 17928571 17519947 16731534 17007740 17974986 16364871 15792986 15505089 17924179 17131338 15811867 16109756 17382496 15476868 16278810 16455267 16269455 17329180 16952015 16651473 16612575 18627295 17308081 17351982 16242529 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.92 | 17334414 16243910 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.24 | 16332659 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
3.04 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.88 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.88 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
10.88 | 16192471 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.50 | 16129372 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.51 | 16835633 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
9.51 | 18291259 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.96 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.96 | 17333356 11677210 16919318 15861022 17110522 16105132 17681005 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.96 | 19176532 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.08 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.64 | 16354765 12621046 15668235 15340226 8697196 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.64 | 9407595 |
| MESH:D003092 |
Colitis |
|
Thalidomide |
9.60 | 16680017 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
9.60 | 17035595 |
| MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.82 | 16340194 17725105 17169374 16510598 17172411 15001691 17287894 18772588 17016597 17018589 |
| MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.82 | 17182828 |
| MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
5.82 | 17287894 17725105 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
4.80 | 19934284 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.80 | 18802399 18259882 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.80 | 16391804 17094418 17401013 18448328 16524972 14970324 20501625 17255274 16282729 18509181 15148649 17016601 17695437 18288408 16331619 17454858 18802399 18949393 16303861 15289873 17594712 18383874 |
| MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
4.80 | 16391804 17454858 15273666 18259882 17159606 16303861 18509181 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 14669216 17141729 |
| MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
5.48 | 9301478 |
| MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
6.22 | 9200351 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 15322242 10048152 20055451 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
3.85 | 9200351 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.85 | 9664655 17551590 9125849 16925845 9142499 8800419 14991402 10589399 9224671 9211117 |
| MESH:D003424 |
Crohn Disease |
|
Thalidomide |
4.12 | 16078585 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.93 | 18551238 |
| MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.71 | 16733453 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.38 | 18249437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.26 | 16647724 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.26 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.08 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.08 | 17416283 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.08 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.89 | 18602426 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.89 | 11462148 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
6.27 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.27 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.67 | 15322242 16714409 18230668 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.67 | 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.10 | 12538720 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.50 | 16402032 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
12.20 | 17359293 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
12.20 | 11473722 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.20 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.94 | 10568697 9294722 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.08 | 18037988 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.44 | 20426865 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.44 | 16481741 16785472 17638652 16337965 15173087 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.61 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.61 | 9664655 16938888 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.52 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.52 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.52 | 19236843 20131406 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.37 | 11858732 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.50 | 19069698 |
| MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.85 | 10962813 14633661 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.22 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.22 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.22 | 17994277 |
| MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
6.22 | 12701121 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.13 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
11.60 | 17150277 |
| MESH:D005909 |
Glioblastoma |
|
Genistein |
11.60 | 16598420 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
11.60 | 17312396 |
| MESH:D005910 |
Glioma |
|
Fluorouracil |
6.35 | 16145905 |
| MESH:D005910 |
Glioma |
|
Thalidomide |
6.35 | 16327979 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.51 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.63 | 15692506 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
12.63 | 18337622 15162350 15102660 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
12.63 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.08 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.38 | 10048152 11294989 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.38 | 9664655 14991402 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.42 | 16707910 16244371 16330681 14766674 18006777 12587719 17875725 16495754 18674790 16244372 17888722 16879835 16144979 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.87 | 17481944 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.87 | 20558911 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.82 | 15692506 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.34 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.25 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.97 | 19176532 18467677 19772884 16221962 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.97 | 12621046 16120746 15340226 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.33 | 18501091 15147373 17606976 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.96 | 18606429 8697196 16354765 16959395 15340226 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.14 | 16870215 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.48 | 16778211 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.10 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.83 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.83 | 18850075 18670907 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.72 | 16945680 16569931 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.38 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.43 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.18 | 12200463 12878042 |
| MESH:D007249 |
Inflammation |
|
Thalidomide |
5.18 | 16134734 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.57 | 16306350 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.68 | 17994277 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.66 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.66 | 17551590 15992940 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.36 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.94 | 8314463 10903974 18776723 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
5.94 | 15369732 16775033 15699352 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.07 | 16707910 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
11.98 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.98 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
11.98 | 16985049 |
| MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
4.27 | 16514283 |
| MESH:D007938 |
Leukemia |
|
Azacitidine |
10.36 | 19148494 |
| MESH:D007938 |
Leukemia |
|
Genistein |
10.36 | 17468513 18980019 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
10.36 | 17143497 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.08 | 16085563 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
9.52 | 19077051 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.52 | 16932348 16482212 19285840 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
6.29 | 17596541 18720364 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
6.29 | 18720364 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
6.29 | 17596541 16294345 19850784 |
| MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.11 | 19299654 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.09 | 15748426 17361223 16766008 17217047 17368321 16788101 16331271 17649720 16891316 17107899 17301526 17294898 17506722 16823087 19029980 19642359 19075265 16140955 19225113 17339181 16935935 9834237 12679006 19035177 17712046 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
8.34 | 10473037 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
8.34 | 9224671 |
| MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
3.96 | 16943688 17174718 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.61 | 16439617 16595196 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
8.61 | 17823541 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
8.61 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.61 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
8.61 | 15465738 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.61 | 16248980 18397230 |
| MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
10.46 | 18383874 16603448 17045692 15113037 |
| MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
10.46 | 15113037 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.46 | 20007298 15890375 16377806 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.46 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.61 | 17085340 16842330 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
9.61 | 1399818 598648 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.61 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
6.51 | 21224363 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.51 | 6189445 17418594 |
| MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
6.51 | 15246190 |
| MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
6.51 | 20970405 1399818 9230183 10545420 16337739 11893704 16271038 6695378 7750092 15390079 21163286 20512841 17909032 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.51 | 11884234 19555203 |
| MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.71 | 15086387 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.40 | 16098063 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.72 | 17654614 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.48 | 15621674 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
13.92 | 11921183 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
13.92 | 12807724 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
13.92 | 15458769 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
13.92 | 14578162 12929590 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.75 | 17453147 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.20 | 16827129 |
| MESH:D008545 |
Melanoma |
|
Thalidomide |
5.20 | 16098027 17089043 12829675 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
5.20 | 16752155 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.34 | 16940565 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.02 | 17638057 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.71 | 16801185 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.42 | 15792986 |
| MESH:D009006 |
Monosomy |
|
Azacitidine |
6.00 | 19299654 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.56 | 16757204 18986760 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
12.13 | 17415656 |
| MESH:D052016 |
Mucositis |
|
irinotecan |
12.13 | 17159606 |
| MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
7.79 | 19549372 18443271 |
| MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
7.79 | 15920492 15867202 16445831 19112201 19372569 15939924 15744524 17168659 15741222 19112817 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.42 | 16239165 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
12.28 | 17596541 19805378 17611569 18720364 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
12.28 | 18720364 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
12.28 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.27 | 15857846 19429709 |
| MESH:D009203 |
Myocardial Infarction |
|
Genistein |
9.27 | 17141266 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.27 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.95 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.16 | 17141266 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.16 | 16411023 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.77 | 18551238 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.99 | 18259882 |
| MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
5.99 | 18259882 |
| MESH:D009369 |
Neoplasms |
|
Fluorouracil |
8.00 | 18239605 18600527 16928823 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.00 | 17405874 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.00 | 16946489 16594593 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.68 | 16636307 16899518 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.36 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.04 | 18481113 19348381 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.04 | 15640375 16889571 |
| MESH:D009421 |
Nervous System Malformations |
|
Genistein |
22.80 | 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
22.80 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
22.80 | 16859833 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
22.80 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.00 | 9142499 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.01 | 15555623 |
| MESH:D009447 |
Neuroblastoma |
|
irinotecan |
7.01 | 8761367 |
| MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.64 | 8761367 |
| MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
8.34 | 16436463 |
| MESH:D020258 |
Neurotoxicity Syndromes |
|
Malathion |
8.34 | 15081274 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.79 | 20558911 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.35 | 12819281 16049721 |
| MESH:D010024 |
Osteoporosis |
|
Genistein |
3.20 | 19401787 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.00 | 16169203 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.04 | 15930896 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
7.91 | 19005980 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
7.91 | 16288038 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.91 | 16936753 |
| MESH:D010146 |
Pain |
|
Tretinoin |
2.83 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
8.59 | 19003803 16929163 16500647 15113037 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
8.59 | 15113037 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.59 | 15976015 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.60 | 11578682 |
| MESH:D010291 |
Paresis |
|
Thalidomide |
6.22 | 9200351 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.17 | 12520081 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.08 | 17983394 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.08 | 17638057 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.47 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.14 | 12371664 |
| MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
4.18 | 17031469 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.11 | 11399792 11222880 11896295 11118676 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
1.91 | 18324645 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.91 | 18437689 15749863 15897917 16729912 16868541 16888761 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.91 | 19082440 18626508 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
1.91 | 16925846 15378649 15256057 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
1.91 | 16729912 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.52 | 16636307 |
| MESH:D011536 |
Prurigo |
|
Thalidomide |
6.22 | 12755975 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.23 | 16919318 15861022 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.20 | 16882103 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.71 | 16723453 |
| MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.93 | 16160472 15538739 18286688 18722050 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.13 | 17922066 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.34 | 19058328 |
| MESH:D012135 |
Respiratory Sounds |
|
Malathion |
5.18 | 17119214 11874814 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 18990726 |
| MESH:D012140 |
Respiratory Tract Diseases |
|
Malathion |
5.44 | 17119214 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.02 | 16283617 16116481 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.91 | 17710206 15675481 16767912 18313854 15625365 17203757 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.16 | 14601052 16326096 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.70 | 17846226 |
| MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
5.85 | 16096327 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.47 | 18551238 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.24 | 15692506 |
| MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.24 | 8532709 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.24 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.24 | 16467112 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.48 | 17203757 16767912 15625365 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.86 | 16709447 |
| MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.42 | 18396642 16951190 16424979 15786421 18567086 17172411 19015929 19084572 17522103 17498489 |
| MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.42 | 15723263 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.42 | 17261132 |
| MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
4.09 | 15138204 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.54 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.07 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.82 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.08 | 16010429 17909728 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.08 | 17045167 16026305 |
| MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.56 | 16280240 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.56 | 16051514 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.17 | 16040207 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.07 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.07 | 17653716 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.23 | 10091137 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.19 | 16803524 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.19 | 16129372 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.21 | 14692618 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.53 | 16752155 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.90 | 1336536 |
| MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
5.40 | 15741222 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.51 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.46 | 14671159 15869587 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.13 | 17678736 17638931 16364871 17334414 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.97 | 16761959 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.17 | 15886252 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.89 | 16287080 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.36 | 17120751 |